Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team.

Pediatrics

Volumn 103, Issue 5, 1999, Pages

  Kline, M W ^a   Van Dyke, R B ^a   Lindsey, J C ^a   Gwynne, M ^a   Culnane, M ^a   Diaz, C ^a   Yogev, R ^a   McKinney Jr , R E ^a   Abrams, E J ^a   Mofenson, L M ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; STAVUDINE; VIRUS RNA;

ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; ISOLATION AND PURIFICATION; MALE; NONPARAMETRIC TEST; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DIDANOSINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; MALE; RNA, VIRAL; STATISTICS, NONPARAMETRIC; STAVUDINE;

EID: 17644442890     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.103.5.e62     Document Type: Article

References (0)